FDA’s new AI labeling push could change how patients and clinicians judge medical devices
The FDA is moving toward clearer labeling for AI-enabled medical devices, especially in cardiology. The goal is simple: help patients and clinicians understand what the software does, who is overseeing it, and what is known about its performance before they decide how much to trust it.
